Exagen Inc.

Contributing Author

Recent Articles by Exagen Inc.

Aug-06	Exagen Inc. to Participate in Third Quarter Investor Conferences XGN GlobeNewswire
Jul-29	Exagen Inc. Reports Strong Q2 2025 Results XGN GlobeNewswire
Jul-17	Exagen Inc. Appoints Chas McKhann to Board of Directors XGN GlobeNewswire
Jul-15	Exagen Inc. to Announce Second Quarter 2025 Financial Results on July 29, 2025 XGN GlobeNewswire
Jun-23	Michael Mahler, PhD Joins Exagen as Chief Scientific Officer to Enhance Leadership in Autoimmune Diagnostics XGN GlobeNewswire
May-09	Exagen Inc. Announces Closing of $20.2 Million Public Offering Including Full Exercise of Underwriter's Option to Purchase Additional Shares XGN GlobeNewswire
May-08	Exagen Inc. Prices Public Offering of Common Stock XGN GlobeNewswire
May-07	Exagen Inc. Announces Proposed Public Offering of Common Stock XGN GlobeNewswire
May-05	Exagen Inc. Reports Record Q1 2025 Revenue Driven by Growth in Average Selling Price and Testing Volume XGN GlobeNewswire